United States  

Trusted News Discovery Since 2008
One News Page
One News Page United States > In the News > Insys Therapeutics Facts and News Updates

Insys Therapeutics

American pharmaceutical manufacturer involved in the opioid epidemic

Insys Therapeutics    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Insys Therapeutics is an American specialty pharmaceutical company based in Chandler, Arizona. Its main product is Subsys, a sublingual liquid form of fentanyl. The drug fentanyl is a very fast acting and powerful opioid used to relieve peaks of pain in cancer patients.


Insys Founder Gets 5½ Years in Prison in Opioid Kickback Scheme

The company executive, John Kapoor, was accused of bribing doctors and misleading insurers to increase sales of a highly addictive painkiller.
NYTimes.com - Published

John Kapoor, founder of Insys Therapeutics, sentenced to 66 months in landmark fentanyl bribery case

John Kapoor, billionaire founder of drug company Insys Therapeutics, was sentenced for orchestrating the scheme of bribes and bogus prescriptions by doctors.
USATODAY.com - Published

Videos for Insys Therapeutics

Insys Founder Kapoor Sentenced For Role In Opioid Racket [Video]Insys Founder Kapoor Sentenced For Role In Opioid Racket

Insys Therapeutics founder John Kapoor was sentenced to 66 months in prison on Thursday. Reuters reports Kapoor is being jailed for his role in an opioid fraud scheme. The billionaire is among a group..

Credit: Wochit News     Duration: 00:34Published


Insys founder Kapoor sentenced to 66 months in prison: judge

Insys Therapeutics founder John Kapoor was sentenced to 66 months in prison for his role in an opioid fraud scheme by a U.S. district judge in Boston on Thursday.
Reuters - Published

New York doctor convicted of taking kickbacks from opioid maker Insys

A New York doctor was convicted on Thursday of accepting thousands of dollars in bribes and kickbacks from Insys Therapeutics Inc in exchange for prescribing his patients an addictive fentanyl spray..
Reuters - Published

Judge partly vacates convictions of opioid maker Insys' founder, executives

A federal judge on Tuesday partially overturned the convictions of Insys Therapeutics Inc's founder and three former executives accused of bribing doctors to prescribe an addictive opioid, but declined..
Reuters - Published

Bankrupt Insys reaches deal to divvy cash among opioid victims

Drugmaker Insys Therapeutics Inc outlined a deal on Thursday to divide its dwindling cash among governments, insurers, hospitals and individuals who accused the company of fueling the U.S. opioid..
Reuters - Published

Drugmaker Insys wins bankruptcy court approval to sell off opioid

Drugmaker Insys Therapeutics Inc on Thursday won court approval to sell its flagship fentanyl spray to a buyer who agreed to only market the drug for use by cancer patients, in response to concerns..
Reuters - Published

Insys, the Opioid Drug Maker, Files for Bankruptcy

The company recently settled with the federal government over claims it illegally marketed its fentanyl painkiller.
NYTimes.com - Published

Opioid maker Insys files for bankruptcy after $225 million settlement

The first opioid maker to file for bankruptcy did so just days after reaching a $225 settlement over doctor bribes
CBS News - Published

Unit of drugmaker Insys pleads guilty to U.S. opioid bribe scheme

A unit of Insys Therapeutics Inc pleaded guilty on Friday to fraud charges as part of an $225 million deal with the U.S. Justice Department resolving claims that the drugmaker bribed doctors to..
Reuters - Published

Opioid drugmaker Insys Chairman Steven Meyer quits after settlement with DoJ

Insys Therapeutics Inc said on Thursday Chairman Steven Meyer and board member Pierre Lapalme will resign, a day after the opioid drugmaker agreed to settle a kickback probe with the U.S. Department of..
Reuters - Published

Insys, the Opioid Drug Maker, to Pay $225 Million to Settle Fraud Charges

Federal prosecutors accused the company of illegally marketing its powerful fentanyl painkiller and of defrauding government health care programs.
NYTimes.com - Published

You Might Like

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2020 One News Page Ltd. All Rights Reserved.
About us  |  Contact us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  In the News  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? FeedbackSend us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter  •  FOLLOW us on Pinterest
One News® is a registered trademark of One News Page Ltd.